Verisk Reiterates its Growth Targets and Outlines Strategy for its Next Phase of Compounding Growth at 2026 Investor Day

Verisk Reiterates its Growth Targets and Outlines Strategy for its Next Phase of Compounding Growth at 2026 Investor Day GlobeNewswire March 05, 2026 JERSEY CITY, N.J., March 05, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will host its Investor Day today at […]

Lantronix Advances Platform Scaling Strategy With MediaTek-Based Embedded Compute Expansion

Lantronix Advances Platform Scaling Strategy With MediaTek-Based Embedded Compute Expansion Strategic expansion strengthens multi-silicon platform strategy, broadens addressable market and accelerates growth across Industrial IoT and Edge AI GlobeNewswire March 05, 2026 IRVINE, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (Nasdaq: LTRX), a global leader in compute and connectivity IoT solutions powering Edge

PPHC To Report Fourth Quarter and Full Year 2025 Financial Results on March 23, 2026

PPHC To Report Fourth Quarter and Full Year 2025 Financial Results on March 23, 2026 GlobeNewswire March 05, 2026 WASHINGTON, March 05, 2026 (GLOBE NEWSWIRE) — Public Policy Holding Company, Inc. (“PPHC” or “the Company”) (Nasdaq: PPHC) (AIM: PPHC), a leading global strategic communications provider offering a comprehensive range of advisory services in the areas

Eclipse Foundation showcases open source innovation at embedded world 2026; Releases 2025 IoT and Embedded Survey Report

Eclipse Foundation showcases open source innovation at embedded world 2026; Releases 2025 IoT and Embedded Survey Report Members Eurotech and Codethink join the Eclipse Foundation in Hall 4, booth 4-554 GlobeNewswire March 05, 2026 BRUSSELS, March 05, 2026 (GLOBE NEWSWIRE) — The Eclipse Foundation, one of the world's largest open source software foundations, will highlight

Media Advisory — SATURDAY: Thousands to Rally in Toronto for 48th Annual International Women’s Day March

Media Advisory — SATURDAY: Thousands to Rally in Toronto for 48th Annual International Women's Day March GlobeNewswire March 05, 2026 TORONTO, March 05, 2026 (GLOBE NEWSWIRE) — Thousands are expected to gather on Saturday, March 7, 2026, for Toronto's 48th annual International Women's Day (IWD) March and Rally — the longest-running annual IWD rally in

Colliers Appoints Christian Mayer and Elias Mulamoottil to Expanded Global Leadership Roles

Colliers Appoints Christian Mayer and Elias Mulamoottil to Expanded Global Leadership Roles Planned transition strengthens largest platforms and recognizes Chris McLernon's retirement GlobeNewswire March 05, 2026 TORONTO, March 05, 2026 (GLOBE NEWSWIRE) — Colliers (NASDAQ, TSX: CIGI), a leading diversified professional services and investment management company, today announced two key executive appointments that reinforce the

GlobalFoundries Announces 2026 Investor Day

GlobalFoundries Announces 2026 Investor Day GlobeNewswire March 05, 2026 MALTA, N.Y., March 05, 2026 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host its Investor Day on Thursday, May 7, 2026, beginning at 9:00 a.m. ET in New York City. GlobalFoundries' Investor Day will feature presentations from its leadership team regarding the

Immatics Announces Full Year 2025 Financial Results and Business Update

Immatics Announces Full Year 2025 Financial Results and Business Update GlobeNewswire March 05, 2026 Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of both cutaneous and uveal melanoma SUPRAME timelines remain unchanged;

Herantis Pharma releases 2H and FY 2025 report today

Herantis Pharma releases 2H and FY 2025 report today GlobeNewswire March 05, 2026 Herantis Pharma Plc | Company Release | March 5, 2026 at 08:00:00 EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc (“Herantis”) a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson's disease, releases today the Company's 2H and FY

Geneva Association Women in Insurance Award honours Elena Sanz, CEO Mapfre Iberia, for outstanding, people-centred leadership

Geneva Association Women in Insurance Award honours Elena Sanz, CEO Mapfre Iberia, for outstanding, people-centred leadership GlobeNewswire March 05, 2026 ZURICH, March 05, 2026 (GLOBE NEWSWIRE) — Elena Sanz, CEO of Mapfre Iberia, has been named this year's recipient of the Geneva Association Women in Insurance Award, in recognition of her exceptional leadership through a

Scroll to Top